High-Fat Meal Increase Blonanserin Bioavailability 5-Fold in Chinese Healthy Subjects
Xue Sun, Haojing Song, Na Zhao, Bo Qiu, Congyang Ding, Huizhen Wu, Wanjun Bai Department of Pharmacy, Hebei General Hospital, Hebei Key Laboratory of Clinical Pharmacy, Shijiazhuang, 050051, People’s Republic of ChinaCorrespondence: Huizhen Wu, Department of Pharmacy, Hebei General Hospital, Hebei K...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-07-01
|
| Series: | Drug Design, Development and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/high-fat-meal-increase-blonanserin-bioavailability-5-fold-in-chinese-h-peer-reviewed-fulltext-article-DDDT |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849715077299568640 |
|---|---|
| author | Sun X Song H Zhao N Qiu B Ding C Wu H Bai W |
| author_facet | Sun X Song H Zhao N Qiu B Ding C Wu H Bai W |
| author_sort | Sun X |
| collection | DOAJ |
| description | Xue Sun, Haojing Song, Na Zhao, Bo Qiu, Congyang Ding, Huizhen Wu, Wanjun Bai Department of Pharmacy, Hebei General Hospital, Hebei Key Laboratory of Clinical Pharmacy, Shijiazhuang, 050051, People’s Republic of ChinaCorrespondence: Huizhen Wu, Department of Pharmacy, Hebei General Hospital, Hebei Key Laboratory of Clinical Pharmacy, Shijiazhuang, 050051, People’s Republic of China, Tel +86-0311-85988064, Email 13582005982@163.com Wanjun Bai, Department of Pharmacy, Hebei General Hospital, Hebei Key Laboratory of Clinical Pharmacy, Shijiazhuang, 050051, People’s Republic of China, Tel +86-0311-85988326, Email baiwanjun0311@163.comPurpose: Although blonanserin is widely used in clinical practice, existing studies have shown significant variations in the magnitude of food effects on its pharmacokinetics. This study was conducted to evaluate the impact of food on the pharmacokinetics and safety of 4-mg blonanserin tablets in healthy Chinese subjects.Methods: The findings were derived from a bioequivalence study in which subjects were randomly assigned to receive blonanserin tablets under fasting or fed conditions. Serial blood samples were collected and plasma concentrations of blonanserin were accurately determined using a validated high-performance liquid chromatography-mass spectrometry (HPLC-MS/MS). Pharmacokinetic parameters, including the maximum plasma concentration (Cmax), the area under the concentration-time curve from zero to the last quantifiable time point (AUC0-t), and the area under the concentration-time curve from zero to infinity (AUC0–∞) were estimated using the non-compartmental method and statistically analyzed by the BE module of WinNonLin. Safety assessments were performed throughout the study period.Results: 106 healthy subjects were enrolled and divided into a fasted group and a fed group. The Cmax, AUC0-t and AUC0–∞ of blonanserin in plasma after a high-fat meal increased 5.23-fold, 4.77-fold and 4.82-fold, relative to the fasted conditions. The 90% confidence interval (90% CI) were outside the 80.00– 125.00% range. The incidence of adverse drug reaction (ADR) was similar between the fasted group and the fed group, with the majority being mild in severity.Conclusion: The results revealed that a high-fat meal significantly increased blonanserin bioavailability by approximately 5-fold at the 4-mg dose. Blonanserin was well tolerated in most subjects under both fasting and fed conditions, and food intake did not significantly alter its safety profile. These findings highlight the need to consider food effects when determining clinical dosing regimens.Keywords: blonanserin, high-fat meal, pharmacokinetics, safety |
| format | Article |
| id | doaj-art-bc41999db4d5410886fc83fcc584c2e6 |
| institution | DOAJ |
| issn | 1177-8881 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Drug Design, Development and Therapy |
| spelling | doaj-art-bc41999db4d5410886fc83fcc584c2e62025-08-20T03:13:30ZengDove Medical PressDrug Design, Development and Therapy1177-88812025-07-01Volume 19Issue 160616072104824High-Fat Meal Increase Blonanserin Bioavailability 5-Fold in Chinese Healthy SubjectsSun X0Song H1Zhao N2Qiu B3Ding C4Wu H5Bai W6Department of PharmacyDepartment of PharmacyDepartment of PharmacyDepartment of PharmacyDepartment of PharmacyDepartment of PharmacyDepartment of PharmacyXue Sun, Haojing Song, Na Zhao, Bo Qiu, Congyang Ding, Huizhen Wu, Wanjun Bai Department of Pharmacy, Hebei General Hospital, Hebei Key Laboratory of Clinical Pharmacy, Shijiazhuang, 050051, People’s Republic of ChinaCorrespondence: Huizhen Wu, Department of Pharmacy, Hebei General Hospital, Hebei Key Laboratory of Clinical Pharmacy, Shijiazhuang, 050051, People’s Republic of China, Tel +86-0311-85988064, Email 13582005982@163.com Wanjun Bai, Department of Pharmacy, Hebei General Hospital, Hebei Key Laboratory of Clinical Pharmacy, Shijiazhuang, 050051, People’s Republic of China, Tel +86-0311-85988326, Email baiwanjun0311@163.comPurpose: Although blonanserin is widely used in clinical practice, existing studies have shown significant variations in the magnitude of food effects on its pharmacokinetics. This study was conducted to evaluate the impact of food on the pharmacokinetics and safety of 4-mg blonanserin tablets in healthy Chinese subjects.Methods: The findings were derived from a bioequivalence study in which subjects were randomly assigned to receive blonanserin tablets under fasting or fed conditions. Serial blood samples were collected and plasma concentrations of blonanserin were accurately determined using a validated high-performance liquid chromatography-mass spectrometry (HPLC-MS/MS). Pharmacokinetic parameters, including the maximum plasma concentration (Cmax), the area under the concentration-time curve from zero to the last quantifiable time point (AUC0-t), and the area under the concentration-time curve from zero to infinity (AUC0–∞) were estimated using the non-compartmental method and statistically analyzed by the BE module of WinNonLin. Safety assessments were performed throughout the study period.Results: 106 healthy subjects were enrolled and divided into a fasted group and a fed group. The Cmax, AUC0-t and AUC0–∞ of blonanserin in plasma after a high-fat meal increased 5.23-fold, 4.77-fold and 4.82-fold, relative to the fasted conditions. The 90% confidence interval (90% CI) were outside the 80.00– 125.00% range. The incidence of adverse drug reaction (ADR) was similar between the fasted group and the fed group, with the majority being mild in severity.Conclusion: The results revealed that a high-fat meal significantly increased blonanserin bioavailability by approximately 5-fold at the 4-mg dose. Blonanserin was well tolerated in most subjects under both fasting and fed conditions, and food intake did not significantly alter its safety profile. These findings highlight the need to consider food effects when determining clinical dosing regimens.Keywords: blonanserin, high-fat meal, pharmacokinetics, safetyhttps://www.dovepress.com/high-fat-meal-increase-blonanserin-bioavailability-5-fold-in-chinese-h-peer-reviewed-fulltext-article-DDDTBlonanserinhigh fat mealpharmacokineticssafety |
| spellingShingle | Sun X Song H Zhao N Qiu B Ding C Wu H Bai W High-Fat Meal Increase Blonanserin Bioavailability 5-Fold in Chinese Healthy Subjects Drug Design, Development and Therapy Blonanserin high fat meal pharmacokinetics safety |
| title | High-Fat Meal Increase Blonanserin Bioavailability 5-Fold in Chinese Healthy Subjects |
| title_full | High-Fat Meal Increase Blonanserin Bioavailability 5-Fold in Chinese Healthy Subjects |
| title_fullStr | High-Fat Meal Increase Blonanserin Bioavailability 5-Fold in Chinese Healthy Subjects |
| title_full_unstemmed | High-Fat Meal Increase Blonanserin Bioavailability 5-Fold in Chinese Healthy Subjects |
| title_short | High-Fat Meal Increase Blonanserin Bioavailability 5-Fold in Chinese Healthy Subjects |
| title_sort | high fat meal increase blonanserin bioavailability 5 fold in chinese healthy subjects |
| topic | Blonanserin high fat meal pharmacokinetics safety |
| url | https://www.dovepress.com/high-fat-meal-increase-blonanserin-bioavailability-5-fold-in-chinese-h-peer-reviewed-fulltext-article-DDDT |
| work_keys_str_mv | AT sunx highfatmealincreaseblonanserinbioavailability5foldinchinesehealthysubjects AT songh highfatmealincreaseblonanserinbioavailability5foldinchinesehealthysubjects AT zhaon highfatmealincreaseblonanserinbioavailability5foldinchinesehealthysubjects AT qiub highfatmealincreaseblonanserinbioavailability5foldinchinesehealthysubjects AT dingc highfatmealincreaseblonanserinbioavailability5foldinchinesehealthysubjects AT wuh highfatmealincreaseblonanserinbioavailability5foldinchinesehealthysubjects AT baiw highfatmealincreaseblonanserinbioavailability5foldinchinesehealthysubjects |